蒙牛乳業(02319.HK):料今年上半年銷售受疫情之不利影響
蒙牛乳業(02319.HK)公布,面對新型冠狀病毒肺炎疫情爆發,集團部分產品運輸線路受到限制,售點運作和產品周轉受到較大影響,從而影響集團2020年2月至3月的銷售,以及上下游全供應鏈的正常運作。
此外,集團2020年2月至3月額外成本增加,主因集團為保證員工健康安全、正常復工復產而投入額外疫情防控費用;集團投入了額外營銷費用,以儘快降低渠道庫存,加速恢復正常的銷售節奏;及集團向社會捐贈款物。因此董事會預計疫情爆發可能會對集團今年上半年度的銷售及財務表現產生不利影響。由於市場及行業仍然受疫情的影響,公司難以量化其對集團今年上半年度的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.